Author Affiliations: Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy (Mr Maisonneuve; firstname.lastname@example.org); and Department of Internal Medicine, Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milan, Italy (Dr Bruno).
To the Editor: Dr van der Meer and colleagues1 demonstrated that sustained virological response (SVR) to interferon-based treatment is associated with lower all-cause mortality among patients with chronic hepatitis C virus (HCV) infection and advanced hepatic fibrosis. As a secondary aim, the authors evaluated the effect of SVR on the risk of hepatocellular carcinoma.
Maisonneuve P, Bruno S. Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C. JAMA. 2013;309(14):1457. doi:10.1001/jama.2013.2726